Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FL0D1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $34,716
Award facts
- Contract value 100% obligated
- $34,715.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $34,715.50 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. The delivery order, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, carries no set-aside designation, indicating the award was made through open competition. DMS Pharmaceutical Group was selected as the awardee based on its established capability as a critical supplier within the federal pharmaceutical supply chain serving the Department of Defense.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The underlying IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceuticals and medical consumables to support the recurring medical supply needs of military healthcare facilities worldwide. The contract structure spans a 30-month base period with three 30-month option periods through December 31, 2036, positioning DMS Pharmaceutical Group as a key regional prime vendor contractor supporting Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB26FL0D1?
SPE2DB26FL0D1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 31, 2025.
How much is contract SPE2DB26FL0D1 worth?
The government has obligated $34,716 on SPE2DB26FL0D1.
Is contract SPE2DB26FL0D1 an order under another contract?
Yes. SPE2DB26FL0D1 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB26FL0D1 competed?
The extent of competition for SPE2DB26FL0D1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award